| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.982 | 0.001 | 0.985 | Psychostimulant | 0.985 0.001 DBMET01172 0.97 0.002 DBMET00313 | DBMET01172 | |
| 0.979 | 0.004 | 0.988 | Analgesic | 0.976 0.004 DBMET01172 0.988 0.003 DBMET00313 | DBMET00313 | |
| 0.937 | 0.002 | 0.975 | Analgesic, opioid | 0.935 0.002 DBMET01172 0.975 0.001 DBMET00313 | DBMET00313 | |
| 0.829 | 0.002 | 0.87 | Opioid antagonist | 0.835 0.002 DBMET01172 0.87 0.001 DBMET00313 | DBMET00313 | |
| 0.819 | 0.004 | 0.858 | Spasmolytic | 0.848 0.004 DBMET01172 0.858 0.004 DBMET00313 | DBMET00313 | |
| 0.806 | 0.002 | 0.877 | Opioid agonist | 0.814 0.002 DBMET01172 0.877 0.002 DBMET00313 | DBMET00313 | |
| 0.804 | 0.002 | 0.881 | Anesthetic general | 0.814 0.002 DBMET01172 0.881 0.002 DBMET00313 | DBMET00313 | |
| 0.8 | 0.002 | 0.858 | Opioid mu receptor antagonist | 0.807 0.002 DBMET01172 0.858 0.001 DBMET00313 | DBMET00313 | |
| 0.758 | 0.002 | 0.857 | Opioid mu receptor agonist | 0.765 0.002 DBMET01172 0.857 0.001 DBMET00313 | DBMET00313 | |
| 0.754 | 0.002 | 0.798 | Opioid delta receptor antagonist | 0.765 0.002 DBMET01172 0.798 0.001 DBMET00313 | DBMET00313 | |
| 0.75 | 0.005 | 0.775 | 5 Hydroxytryptamine release stimulant | 0.775 0.004 DBMET01172 0.733 0.005 DBMET00313 | DBMET01172 | |
| 0.734 | 0.002 | 0.778 | Opioid kappa receptor antagonist | 0.744 0.002 DBMET01172 0.778 0.001 DBMET00313 | DBMET00313 | |
| 0.695 | 0.021 | 0.718 | Transcription factor NF kappa B inhibitor | 0.718 0.018 DBMET01172 0.622 0.029 DBMET00313 | DBMET01172 | |
| 0.654 | 0.002 | 0.77 | Opioid delta receptor agonist | 0.678 0.002 DBMET01172 0.77 0.002 DBMET00313 | DBMET00313 | |
| 0.575 | 0.002 | 0.659 | Opioid kappa receptor agonist | 0.576 0.002 DBMET01172 0.659 0.001 DBMET00313 | DBMET00313 | |
| 0.491 | 0.009 | 0.491 | P-glycoprotein inhibitor | 0.423 0.014 DBMET01172 0.382 0.018 DBMET00313 | ||
| 0.483 | 0.011 | 0.553 | Sigma receptor agonist | 0.481 0.011 DBMET01172 0.553 0.005 DBMET00313 | DBMET00313 | |
| 0.521 | 0.079 | 0.521 | Antiinflammatory | 0.48 0.096 DBMET01172 0.486 0.093 DBMET00313 | ||
| 0.478 | 0.039 | 0.491 | Immunosuppressant | 0.484 0.037 DBMET01172 0.491 0.036 DBMET00313 | DBMET00313 | |
| 0.435 | 0.005 | 0.725 | Sigma receptor antagonist | 0.451 0.004 DBMET01172 0.725 0.003 DBMET00313 | DBMET00313 | |
| 0.432 | 0.004 | 0.432 | Expectorant | 0.398 0.005 DBMET01172 0.351 0.006 DBMET00313 | ||
| 0.474 | 0.082 | 0.474 | Apoptosis agonist | 0.46 0.087 DBMET01172 0.388 0.12 DBMET00313 | ||
| 0.419 | 0.049 | 0.419 | Vasodilator, peripheral | 0.317 0.089 DBMET01172 0.257 0.122 DBMET00313 | ||
| 0.324 | 0.005 | 0.324 | Toll-Like receptor antagonist | 0.314 0.006 DBMET01172 0.283 0.009 DBMET00313 | ||
| 0.349 | 0.032 | 0.349 | Nitric oxide antagonist | 0.345 0.032 DBMET01172 0.323 0.036 DBMET00313 | ||
| 0.314 | 0.012 | 0.356 | Antipruritic | 0.31 0.013 DBMET01172 0.356 0.009 DBMET00313 | DBMET00313 | |
| 0.289 | 0.003 | 0.327 | Toll-Like receptor 4 antagonist | 0.301 0.003 DBMET01172 0.327 0.003 DBMET00313 | DBMET00313 | |
| 0.299 | 0.015 | 0.319 | Interleukin 6 antagonist | 0.307 0.014 DBMET01172 0.319 0.013 DBMET00313 | DBMET00313 | |
| 0.314 | 0.048 | 0.314 | Tumour necrosis factor alpha release inhibitor | 0.209 0.101 DBMET01172 0.217 0.095 DBMET00313 | ||
| 0.274 | 0.021 | 0.294 | Protein kinase stimulant | 0.294 0.018 DBMET01172 0.213 0.037 DBMET00313 | DBMET01172 | |
| 0.27 | 0.018 | 0.293 | Cholinergic antagonist | 0.293 0.015 DBMET01172 0.23 0.025 DBMET00313 | DBMET01172 | |
| 0.311 | 0.074 | 0.311 | Caspase 3 stimulant | 0.309 0.074 DBMET01172 0.272 0.095 DBMET00313 | ||
| 0.252 | 0.02 | 0.274 | Acetylcholine antagonist | 0.274 0.017 DBMET01172 0.217 0.027 DBMET00313 | DBMET01172 | |
| 0.234 | 0.013 | 0.618 | Alpha 2 adrenoreceptor antagonist | 0.219 0.015 DBMET01172 0.618 0.004 DBMET00313 | DBMET00313 | |
| 0.221 | 0.006 | 0.232 | Prolactin inhibitor | 0.232 0.005 DBMET01172 0.202 0.008 DBMET00313 | DBMET01172 | |
| 0.24 | 0.028 | 0.308 | Acetylcholine M1 receptor antagonist | 0.308 0.013 DBMET01172 0.302 0.014 DBMET00313 | DBMET01172 | |
| 0.271 | 0.063 | 0.288 | 5 Hydroxytryptamine uptake stimulant | 0.259 0.072 DBMET01172 0.288 0.052 DBMET00313 | DBMET00313 | |
| 0.219 | 0.011 | 0.219 | Acetylcholine nicotinic antagonist | 0.179 0.015 DBMET01172 0.144 0.022 DBMET00313 | ||
| 0.207 | 0.012 | 0.212 | Antineoplastic alkaloid | 0.212 0.01 DBMET01172 0.187 0.017 DBMET00313 | DBMET01172 | |
| 0.228 | 0.051 | 0.228 | Hepatoprotectant | 0.228 0.051 DBMET01172 0.207 0.061 DBMET00313 | ||
| 0.204 | 0.045 | 0.212 | Cholinergic | 0.165 0.066 DBMET01172 0.212 0.041 DBMET00313 | DBMET00313 | |
| 0.255 | 0.096 | 0.417 | Hypoxia-inducible factor 1 alpha inhibitor | 0.323 0.055 DBMET01172 0.417 0.026 DBMET00313 | DBMET00313 | |
| 0.182 | 0.026 | 0.182 | Cyclooxygenase 3 inhibitor | 0.148 0.05 DBMET01172 | ||
| 0.164 | 0.019 | 0.698 | Alpha 2a adrenoreceptor antagonist | 0.222 0.011 DBMET01172 0.698 0.003 DBMET00313 | DBMET00313 | |
| 0.195 | 0.06 | 0.207 | Lipocortins synthesis antagonist | 0.207 0.052 DBMET01172 0.155 0.098 DBMET00313 | DBMET01172 | |
| 0.169 | 0.034 | 0.198 | Acetylcholine muscarinic antagonist | 0.198 0.025 DBMET01172 0.165 0.036 DBMET00313 | DBMET01172 | |
| 0.136 | 0.017 | 0.214 | Dopamine agonist | 0.14 0.016 DBMET01172 0.214 0.009 DBMET00313 | DBMET00313 | |
| 0.118 | 0.003 | 0.132 | Prolactin release inhibitor | 0.117 0.003 DBMET01172 0.132 0.003 DBMET00313 | DBMET00313 | |
| 0.12 | 0.009 | 0.182 | Dopamine D2 agonist | 0.123 0.008 DBMET01172 0.182 0.005 DBMET00313 | DBMET00313 | |
| 0.215 | 0.104 | 0.28 | Antioxidant | 0.273 0.072 DBMET01172 0.28 0.07 DBMET00313 | DBMET00313 | |
| 0.194 | 0.083 | 0.194 | Neurotrophic factor enhancer | 0.176 0.102 DBMET01172 | ||
| 0.125 | 0.017 | 0.128 | ATPase (Vacuolar H+) inhibitor | 0.128 0.015 DBMET01172 0.098 0.042 DBMET00313 | DBMET01172 | |
| 0.205 | 0.1 | 0.205 | Vasodilator | 0.181 0.121 DBMET01172 | ||
| 0.149 | 0.045 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.161 0.022 DBMET01172 0.142 0.065 DBMET00313 | DBMET01172 | |
| 0.244 | 0.14 | 0.244 | Vasodilator, coronary | |||
| 0.152 | 0.054 | 0.155 | Acetylcholinesterase inhibitor | 0.126 0.073 DBMET01172 0.155 0.052 DBMET00313 | DBMET00313 | |
| 0.17 | 0.073 | 0.199 | Growth hormone agonist | 0.199 0.059 DBMET01172 | DBMET01172 | |
| 0.096 | 0.01 | 0.096 | Nitric oxide donor | 0.085 0.018 DBMET01172 | ||
| 0.113 | 0.03 | 0.117 | Alpha 2d adrenoreceptor antagonist | 0.103 0.043 DBMET01172 0.117 0.026 DBMET00313 | DBMET00313 | |
| 0.202 | 0.119 | 0.252 | Immunostimulant | 0.252 0.095 DBMET01172 0.195 0.123 DBMET00313 | DBMET01172 | |
| 0.226 | 0.151 | 0.252 | Apoptosis antagonist | 0.252 0.126 DBMET01172 | DBMET01172 | |
| 0.128 | 0.053 | 0.128 | Microtubule formation inhibitor | 0.126 0.054 DBMET01172 | ||
| 0.097 | 0.025 | 0.1 | Neuronal nicotinic receptor antagonist | 0.082 0.035 DBMET01172 0.1 0.024 DBMET00313 | DBMET00313 | |
| 0.085 | 0.033 | 0.115 | Glycine receptor agonist | 0.115 0.014 DBMET01172 0.089 0.028 DBMET00313 | DBMET01172 | |
| 0.099 | 0.047 | 0.138 | Antineoplastic antibiotic | 0.111 0.042 DBMET01172 0.138 0.034 DBMET00313 | DBMET00313 | |
| 0.274 | 0.223 | 0.285 | Caspase 9 stimulant | 0.285 0.211 DBMET01172 | DBMET01172 | |
| 0.105 | 0.054 | 0.277 | Alpha adrenoreceptor antagonist | 0.277 0.017 DBMET00313 | DBMET00313 | |
| 0.083 | 0.033 | 0.083 | Elastase 1 inhibitor | |||
| 0.061 | 0.019 | 0.123 | Dopamine D5 antagonist | 0.078 0.013 DBMET01172 0.123 0.008 DBMET00313 | DBMET00313 | |
| 0.092 | 0.051 | 0.092 | Acetylcholine M3 receptor agonist | 0.079 0.061 DBMET01172 | ||
| 0.194 | 0.158 | 0.194 | Gastrin inhibitor | |||
| 0.042 | 0.007 | 0.042 | Elastase 3B inhibitor | |||
| 0.042 | 0.007 | 0.042 | Elastase 3A inhibitor | |||
| 0.042 | 0.007 | 0.042 | Elastase 2B inhibitor | |||
| 0.038 | 0.006 | 0.051 | Dopamine D1 agonist | 0.044 0.005 DBMET01172 0.051 0.005 DBMET00313 | DBMET00313 | |
| 0.089 | 0.056 | 0.089 | Calcium antagonist | |||
| 0.047 | 0.016 | 0.097 | Nociceptin (N/OFQ) receptor antagonist | 0.057 0.011 DBMET01172 0.097 0.006 DBMET00313 | DBMET00313 | |
| 0.109 | 0.078 | 0.132 | Alkylator | 0.132 0.057 DBMET01172 | DBMET01172 | |
| 0.078 | 0.048 | 0.078 | Acetylcholine M4 receptor antagonist | |||
| 0.091 | 0.065 | 0.098 | Breast cancer-resistant protein inhibitor | 0.088 0.068 DBMET01172 0.098 0.057 DBMET00313 | DBMET00313 | |
| 0.05 | 0.028 | 0.05 | Microtubule stabilization | 0.05 0.028 DBMET01172 | ||
| 0.086 | 0.066 | 0.148 | Antiadrenergic | 0.148 0.036 DBMET00313 | DBMET00313 | |
| 0.051 | 0.031 | 0.054 | Nicotinic receptor alpha4 subunit antagonist | 0.049 0.035 DBMET01172 0.054 0.027 DBMET00313 | DBMET00313 | |
| 0.101 | 0.082 | 0.101 | Anesthetic local | |||
| 0.054 | 0.036 | 0.054 | Nicotinic receptor alpha7 subunit antagonist | 0.051 0.042 DBMET00313 | ||
| 0.091 | 0.076 | 0.111 | Anabolic | 0.111 0.048 DBMET01172 0.088 0.083 DBMET00313 | DBMET01172 | |
| 0.15 | 0.145 | 0.219 | Free radical scavenger | 0.219 0.084 DBMET01172 0.196 0.101 DBMET00313 | DBMET01172 | |
| 0.139 | 0.134 | 0.139 | Antimitotic | |||
| 0.015 | 0.011 | 0.03 | NMDA receptor phencyclidine site antagonist | 0.015 0.011 DBMET01172 0.03 0.004 DBMET00313 | DBMET00313 | |
| 0.075 | 0.073 | 0.129 | Adrenaline antagonist | 0.129 0.041 DBMET00313 | DBMET00313 | |
| 0.053 | 0.054 | 0.057 | Lipocortins synthesis agonist | 0.057 0.044 DBMET01172 | DBMET01172 | |
| 0.082 | 0.086 | 0.131 | Alpha 2c adrenoreceptor antagonist | 0.131 0.042 DBMET00313 | DBMET00313 | |
| 0.093 | 0.101 | 0.115 | Electron transport complex I inhibitor | 0.102 0.078 DBMET01172 0.115 0.054 DBMET00313 | DBMET00313 | |
| 0.041 | 0.052 | 0.046 | Protein 50S ribosomal subunit inhibitor | 0.046 0.045 DBMET01172 | DBMET01172 | |
| 0.075 | 0.088 | 0.082 | Estrogen-related receptor beta agonist | 0.082 0.06 DBMET01172 | DBMET01172 | |
| 0.013 | 0.027 | 0.029 | Nociceptin (N/OFQ) receptor agonist | 0.029 0.01 DBMET00313 | DBMET00313 | |
| 0.1 | 0.116 | 0.151 | Lipid peroxidase inhibitor | 0.151 0.067 DBMET01172 0.114 0.1 DBMET00313 | DBMET01172 | |
| 0.027 | 0.043 | 0.033 | Nicotinic receptor beta4 subunit antagonist | 0.033 0.031 DBMET00313 | DBMET00313 | |
| 0.043 | 0.059 | 0.053 | Dopamine uptake inhibitor | 0.053 0.046 DBMET00313 | DBMET00313 | |
| 0.198 | 0.217 | 0.213 | Calcium channel activator | 0.213 0.194 DBMET01172 | DBMET01172 | |
| 0.117 | 0.141 | 0.153 | Melanin inhibitor | 0.153 0.078 DBMET01172 0.138 0.1 DBMET00313 | DBMET01172 | |
| 0.092 | 0.118 | 0.115 | Estrogen antagonist | 0.109 0.077 DBMET01172 0.115 0.064 DBMET00313 | DBMET00313 | |
| 0.036 | 0.078 | 0.164 | Dopamine D2 antagonist | 0.164 0.021 DBMET00313 | DBMET00313 | |
| 0.072 | 0.122 | 0.154 | Adenylate cyclase inhibitor | 0.154 0.042 DBMET01172 0.123 0.065 DBMET00313 | DBMET01172 | |
| 0.039 | 0.096 | 0.139 | Dopamine D1 antagonist | 0.07 0.04 DBMET01172 0.139 0.016 DBMET00313 | DBMET00313 | |
| 0.038 | 0.096 | 0.157 | Dopamine antagonist | 0.157 0.024 DBMET00313 | DBMET00313 | |
| 0.099 | 0.165 | 0.135 | NOS3 expression enhancer | 0.135 0.09 DBMET00313 | DBMET00313 | |
| 0.064 | 0.14 | 0.104 | Estrogen receptor beta antagonist | 0.09 0.083 DBMET01172 0.104 0.057 DBMET00313 | DBMET00313 | |
| 0.155 | 0.241 | 0.2 | Tyrosine 3 hydroxylase inhibitor | 0.196 0.143 DBMET01172 0.2 0.136 DBMET00313 | DBMET00313 | |
| 0.125 | 0.216 | 0.165 | DNA damaging | 0.165 0.151 DBMET00313 | DBMET00313 | |
| 0.047 | 0.145 | 0.075 | Glycine receptor antagonist | 0.075 0.065 DBMET00313 | DBMET00313 | |
| 0.151 | 0.266 | 0.206 | Sodium/bile acid cotransporter inhibitor | 0.206 0.18 DBMET00313 | DBMET00313 | |
| 0.053 | 0.175 | 0.106 | Cystathionine beta-synthase inhibitor | 0.092 0.087 DBMET01172 0.106 0.07 DBMET00313 | DBMET00313 | |
| 0.058 | 0.192 | 0.088 | Nav1.1 sodium channel blocker | 0.088 0.083 DBMET00313 | DBMET00313 | |
| 0.126 | 0.279 | 0.183 | Peptidyltransferase inhibitor | 0.183 0.123 DBMET00313 | DBMET00313 | |
| 0.033 | 0.223 | 0.125 | MAO inhibitor | 0.125 0.072 DBMET00313 | DBMET00313 | |
| 0.035 | 0.25 | 0.097 | Creatine kinase inhibitor | 0.097 0.062 DBMET00313 | DBMET00313 | |
| 0.048 | 0.36 | 0.079 | CC chemokine 5 receptor agonist | 0.079 0.067 DBMET00313 | DBMET00313 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |